NCT06287177Recruiting
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy - CHOLINET (CHOLesterol Italian Inclisiran NETwork)
Source: ClinicalTrials.gov · Last updated 22 Jan 2026
Brief summary (registry, in English)
Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 20 Feb 2024
- Start date
- 1 Nov 2022
- Primary completion date
- 29 Feb 2024
- Lead sponsor
- Federico II University
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT06287177
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 1 Nov 2022 to the primary completion date, 29 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \< 18 years o \> 80 years
Other
- Patients who refuse to participate and to sign informed consent
Who the study is looking for
- Patients under Inclisiran treatment
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Federico II University of Naples, Department of Advanced Biomedical Sciences Coordinator of this site? Confirm its status | Naples | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.